Rigel Pharmaceuticals Inc... (RIGL)
16.16
-1.10 (-6.37%)
At close: Apr 10, 2025, 1:05 PM
Rigel Pharmaceuticals Revenue
Rigel Pharmaceuticals reported an annual revenue of $179.28M, reflecting a 53.38% growth. For the quarter ending December 31, 2024, Rigel Pharmaceuticals generated $57.6M in revenue.
Revenue (ttm)
$179.28M
Revenue Growth
53.38%
Price / Sales Ratio
1.65
Revenue / Employee
$1.11M
Employees
162
Market Cap
288.58M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 179.28M | +53.38% |
| Dec 31, 2023 | 116.88M | -2.79% |
| Dec 31, 2022 | 120.24M | -19.43% |
| Dec 31, 2021 | 149.24M | +37.39% |
| Dec 31, 2020 | 108.62M | n/a |